Does TOFACITINIB Cause Peripheral swelling? 7,830 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7,830 reports of Peripheral swelling have been filed in association with TOFACITINIB (XELJANZ XR). This represents 5.0% of all adverse event reports for TOFACITINIB.
7,830
Reports of Peripheral swelling with TOFACITINIB
5.0%
of all TOFACITINIB reports
1,256
Deaths
2,295
Hospitalizations
How Dangerous Is Peripheral swelling From TOFACITINIB?
Of the 7,830 reports, 1,256 (16.0%) resulted in death, 2,295 (29.3%) required hospitalization, and 1,340 (17.1%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 7,830 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
INFLIXIMAB (5,648)
Which TOFACITINIB Alternatives Have Lower Peripheral swelling Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN